?Gleiss Lutz has advised Pitango on the deal. Israeli venture capital investor Pitango announced its investment in digital health startup Patient21. The Berlin-based startup raised a...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz advised Curaleaf in the transaction while Paul Hastings represented Four 20 Pharma. Curaleaf Holdings, Inc., a leading U.S. provider of consumer products in cannabis,...
You must be a Standard 1 Year member to access this content.
Allen & Overy, Morgan Lewis, Dorda and Vinson & Elkins advised DigitalBridge Group, Inc. (NYSE: DBRG) on the deal. Poellath, Noerr, Freshfields Bruckhaus Deringer, Gleiss Lutz,...
You must be a Standard 1 Year member to access this content.
CMS has advised eGym. Gide Loyrette Nouel and Gleiss Lutz advised Gymlib. German fitness technology and corporate fitness provider EGYM acquires French competitor Gymlib. With the...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz advised Integer on the deal while Locke Lord represented Oscor. The US company Integer, a leading medical device outsource manufacturer, announced its USD 220...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Gleiss Lutz, advised on the matter. Gleiss Lutz advised Integer Holdings Corporation with a team including Johannes Hertfelder (Competition Law), Stefan Lingemann (Employment), Martin...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz, Kromann Reumert, Vinge, Loyens & Loeff and Fava & Associati advised Coloplast on the deal. Linklaters advised PAI Partners. Coloplast has signed an agreement...
You must be a Standard 1 Year member to access this content.
FPS Fritze Wicke Seelig advised Bloomwell Group on the deal. Gleiss Lutz advised Measure 8 Ventures. Noerr advises M4Capital. The Bloomwell Group has successfully closed a...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz advised Roche on the deal. Hengeler Mueller advised the shareholders of TIB Mobil Group on the transaction. The global pharmaceutical and diagnostics group Roche...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz advised the shareholders of Hotjar on the deal, alongside with Burges Salmon (England), Fenech & Fenech (Malta), August Debouzy (France) und Cuatrecasas (Spain). Contentsquare,...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz has advised MitrAssist Holdings Limited on the deal. MitrAssist Holdings Limited announced its investment as lead investor in medical technology startup AdjuCor. AdjuCor will...
You must be a Standard 1 Year member to access this content.
Gleiss Lutz advised Netherlands technology group ASML on the deal. ASML Holding NV has divested its subsidiary Berliner Glas Group’s technical glass division to Glas Trösch...
You must be a Standard 1 Year member to access this content.
